Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garth Powis

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Anti-Cancer Drugs|May 17, 2006
Thioredoxin reductase and cancer cell growth inhibition by organogold(III) compoundsLars Engman, Michael McNaughton, Malgorzata Gajewska, et al.
Free Radical Biology & Medicine|January 13, 2009
Superoxide dismutase is regulated by LAMMER kinase in Drosophila and human cellsBrian P James, William D Staatz, Sarah T Wilkinson, et al.
Translational Oncology|June 29, 2012
Tumor Xenograft Response to Redox-Active Therapies Assessed by Magnetic Resonance Imaging Using a Thiol-Bearing DOTA Complex of GadoliniumGerald P Guntle, Bhumasamudram Jagadish, Eugene A Mash, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Stability of phosphoprotein as a biological marker of tumor signalingAmanda F Baker, Tomislav Dragovich, Nathan T Ihle, et al.
Experimental Hematology|June 9, 2004
Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase-dependent clonogenic response in acute myeloid leukemia cellsAlan F List, Betty Glinsmann-Gibson, Chad Stadheim, et al.
Organic & Biomolecular Chemistry|May 27, 2004
Natural product based inhibitors of the thioredoxin-thioredoxin reductase systemPeter Wipf, Stephen M Lynch, Anne Birmingham, et al.
SLAS Discovery : Advancing Life Sciences R & D|August 19, 2017
A Fluorescence-Based High-Throughput Assay for the Identification of Anticancer Reagents Targeting Fructose-1,6-Bisphosphate AldolaseEun Jeong Cho, Ashwini K Devkota, Gabriel Stancu, et al.
NMR in Biomedicine|October 6, 2005
Metabolite changes in HT-29 xenograft tumors following HIF-1alpha inhibition with PX-478 as studied by MR spectroscopy in vivo and ex vivoBénédicte F Jordan, Kvar Black, Ian F Robey, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2006
The skin and hair as surrogate tissues for measuring the target effect of inhibitors of phosphoinositide-3-kinase signalingRyan Williams, Amanda F Baker, Nathan T Ihle, et al.
Molecular Cancer Therapeutics|March 27, 2003
The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formationSarah J Welsh, Ryan R Williams, Anne Birmingham, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Anti-Cancer Drugs|May 17, 2006
Thioredoxin reductase and cancer cell growth inhibition by organogold(III) compoundsLars Engman, Michael McNaughton, Malgorzata Gajewska, et al.
Free Radical Biology & Medicine|January 13, 2009
Superoxide dismutase is regulated by LAMMER kinase in Drosophila and human cellsBrian P James, William D Staatz, Sarah T Wilkinson, et al.
Translational Oncology|June 29, 2012
Tumor Xenograft Response to Redox-Active Therapies Assessed by Magnetic Resonance Imaging Using a Thiol-Bearing DOTA Complex of GadoliniumGerald P Guntle, Bhumasamudram Jagadish, Eugene A Mash, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Stability of phosphoprotein as a biological marker of tumor signalingAmanda F Baker, Tomislav Dragovich, Nathan T Ihle, et al.
Experimental Hematology|June 9, 2004
Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase-dependent clonogenic response in acute myeloid leukemia cellsAlan F List, Betty Glinsmann-Gibson, Chad Stadheim, et al.
Organic & Biomolecular Chemistry|May 27, 2004
Natural product based inhibitors of the thioredoxin-thioredoxin reductase systemPeter Wipf, Stephen M Lynch, Anne Birmingham, et al.
SLAS Discovery : Advancing Life Sciences R & D|August 19, 2017
A Fluorescence-Based High-Throughput Assay for the Identification of Anticancer Reagents Targeting Fructose-1,6-Bisphosphate AldolaseEun Jeong Cho, Ashwini K Devkota, Gabriel Stancu, et al.
NMR in Biomedicine|October 6, 2005
Metabolite changes in HT-29 xenograft tumors following HIF-1alpha inhibition with PX-478 as studied by MR spectroscopy in vivo and ex vivoBénédicte F Jordan, Kvar Black, Ian F Robey, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2006
The skin and hair as surrogate tissues for measuring the target effect of inhibitors of phosphoinositide-3-kinase signalingRyan Williams, Amanda F Baker, Nathan T Ihle, et al.
Molecular Cancer Therapeutics|March 27, 2003
The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formationSarah J Welsh, Ryan R Williams, Anne Birmingham, et al.
Pageof 10